ADAP — Adaptimmune Therapeutics Plc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.05 Analyst target: $0.68 Upside: 1144.08%

See the full interactive analysis & chart →

Informational only — not investment advice.